Point Of Care Diagnostics Market (2026 - 2033) Size, Share & Trends Analysis Report By Product (Infectious Diseases, Glucose Testing, Cardiac Markers), By End Use (Hospitals, Home, Assisted Living Healthcare Facilities, Laboratory), By Region, And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Segment Definitions
                        1.2.1. Product
                        1.2.2. End Use
                        1.2.3. Regional scope
                        1.2.4. Estimates and forecasts timeline
                    1.3. Regional Scope
                    1.4. Estimates and Forecast Timeline
                    1.5. Research Methodology
                    1.6. Information Procurement
                        1.6.1. Purchased Database
                        1.6.2. GVR’s Internal Database
                    1.7. Details of primary research
                    1.8. Market Formulation & Validation
                    1.9. Model Details
                        1.9.1. Commodity flow analysis (Model 1)
                            1.9.1.1. Approach 1: Commodity flow approach
                        1.9.2. Volume price analysis (Model 2)
                            1.9.2.1. Approach 2: Volume price analysis
                    1.10. Research Scope and Assumptions
                        1.10.1. List of Secondary Sources
                        1.10.2. List of Primary Sources
                        1.10.3. Objectives
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                        2.2.1. Product outlook
                        2.2.2. End Use outlook
                        2.2.3. Regional outlook
                    2.3. Competitive Insights
Chapter 3. Point Of Care Diagnostics Market Variables, Trends & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent market outlook
                        3.1.2. Related/ancillary market outlook
                    3.2. Market Dynamics
                        3.2.1. Market driver analysis
                            3.2.1.1. Introduction of CLIA waived tests
                            3.2.1.2. Rise in funding from government and private institutions
                            3.2.1.3. Growing geriatric population base
                            3.2.1.4. Growing prevalence of target diseases
                            3.2.1.5. Growing demand for home healthcare and the introduction of advanced technology enabled products
                        3.2.2. Market restraint analysis
                            3.2.2.1. High procedure costs coupled with limited adoption of POC devices in certain emerging regions
                            3.2.2.2. Presence of ambiguous regulatory as well as reimbursement framework for primary care setting
                        3.2.3. Market challenge analysis
                            3.2.3.1. POC device pose challenges in maintaining the quality standards
                        3.2.4. Market opportunity analysis
                    3.3. Point of Care Diagnostics Market Analysis Tools
                        3.3.1. Porter’s Analysis
                            3.3.1.1. Bargaining power of the suppliers
                            3.3.1.2. Bargaining power of the buyers
                            3.3.1.3. Threats of substitution
                            3.3.1.4. Threats from new entrants
                            3.3.1.5. Competitive rivalry
                        3.3.2. PESTEL Analysis
                            3.3.2.1. Political landscape
                            3.3.2.2. Economic and Social landscape
                            3.3.2.3. Technological landscape
                            3.3.2.4. Legal landscape
                    3.4. Reimbursement Overview of IVDs and LDTs
                    3.5. Pricing Analysis
Chapter 4. Point Of Care Diagnostics Market: Product Estimates & Trend Analysis
                    4.1. Product Market Share, 2025 & 2033
                    4.2. Segment Dashboard
                    4.3. Global Point Of Care Diagnostics Market by Product Outlook
                    4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
                        4.4.1. Glucose Testing
                            4.4.1.1. Market estimates and forecasts 2021 to 2033 (USD Billion)
                        4.4.2. Hb1Ac Testing
                            4.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Billion)
                        4.4.3. Coagulation Testing
                            4.4.3.1. Market estimates and forecasts 2021 to 2033 (USD Billion)
                        4.4.4. Fertility/Pregnancy Testing
                            4.4.4.1. Market estimates and forecasts 2021 to 2033 (USD Billion)
                        4.4.5. Infectious Disease
                            4.4.5.1. Market estimates and forecasts 2021 to 2033 (USD Billion)
                            4.4.5.2. HIV POC
                                4.4.5.2.1. Market estimates and forecasts 2021 to 2033 (USD Billion)
                            4.4.5.3. Clostridium Difficile POC
                                4.4.5.3.1. Market estimates and forecasts 2021 to 2033 (USD Billion)
                            4.4.5.4. HBV POC
                                4.4.5.4.1. Market estimates and forecasts 2021 to 2033 (USD Billion)
                            4.4.5.5. Pneumonia or Streptococcus Associated Infections
                                4.4.5.5.1. Market estimates and forecasts 2021 to 2033 (USD Billion)
                            4.4.5.6. Respiratory Syncytial Virus (RSV) POC
                                4.4.5.6.1. Market estimates and forecasts 2021 to 2033 (USD Billion)
                            4.4.5.7. HPV POC
                                4.4.5.7.1. Market estimates and forecasts 2021 to 2033 (USD Billion)
                            4.4.5.8. Influenza/Flu POC
                                4.4.5.8.1. Market estimates and forecasts 2021 to 2033 (USD Billion)
                            4.4.5.9. HCV POC
                                4.4.5.9.1. Market estimates and forecasts 2021 to 2033 (USD Billion)
                            4.4.5.10. MRSA POC
                                4.4.5.10.1. Market estimates and forecasts 2021 to 2033 (USD Billion)
                            4.4.5.11. TB and drug resistant TB POC
                                4.4.5.11.1. Market estimates and forecasts 2021 to 2033 (USD Billion)
                            4.4.5.12. HSV POC
                                4.4.5.12.1. Market estimates and forecasts 2021 to 2033 (USD Billion)
                            4.4.5.13. COVID-19
                                4.4.5.13.1. Market estimates and forecasts 2021 to 2033 (USD Billion)
                            4.4.5.14. Other infectious diseases
                                4.4.5.14.1. Market estimates and forecasts 2021 to 2033 (USD Billion)
                        4.4.6. Cardiac Markers
                            4.4.6.1. Market estimates and forecasts 2021 to 2033 (USD Billion)
                        4.4.7. Thyroid Stimulating Hormone
                            4.4.7.1. Market estimates and forecasts 2021 to 2033 (USD Billion)
                        4.4.8. Hematology
                            4.4.8.1. Market estimates and forecasts 2021 to 2033 (USD Billion)
                        4.4.9. Primary Care Systems
                            4.4.9.1. Market estimates and forecasts 2021 to 2033 (USD Billion)
                        4.4.10. Decentralized Clinical Chemistry
                            4.4.10.1. Market estimates and forecasts 2021 to 2033 (USD Billion)
                        4.4.11. Feces
                            4.4.11.1. Market estimates and forecasts 2021 to 2033 (USD Billion)
                        4.4.12. Lipid Testing
                            4.4.12.1. Market estimates and forecasts 2021 to 2033 (USD Billion)
                        4.4.13. Cancer Marker
                            4.4.13.1. Market estimates and forecasts 2021 to 2033 (USD Billion)
                        4.4.14. Blood Gas/Electrolytes
                            4.4.14.1. Market estimates and forecasts 2021 to 2033 (USD Billion)
                        4.4.15. Ambulatory Chemistry
                            4.4.15.1. Market estimates and forecasts 2021 to 2033 (USD Billion)
                        4.4.16. Drug of Abuse (DOA) Testing
                            4.4.16.1. Market estimates and forecasts 2021 to 2033 (USD Billion)
                        4.4.17. Autoimmune diseases
                            4.4.17.1. Market estimates and forecasts 2021 to 2033 (USD Billion)
                        4.4.18. Urinalysis/Nephrology
                            4.4.18.1. Market estimates and forecasts 2021 to 2033 (USD Billion)
Chapter 5. Point Of Care Diagnostics Market: End Use Estimates & Trend Analysis
                    5.1. End Use Market Share, 2025 & 2033
                    5.2. Segment Dashboard
                    5.3. Global Point Of Care Diagnostics Market by End Use Outlook
                    5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
                        5.4.1. Clinics
                            5.4.1.1. Market estimates and forecasts 2021 to 2033 (USD billion)
                            5.4.1.2. Pharmacy & Retail Clinics
                                5.4.1.2.1. Market estimates and forecasts 2021 to 2033 (USD Billion)
                            5.4.1.3. Physician Office
                                5.4.1.3.1. Market estimates and forecasts 2021 to 2033 (USD Billion)
                            5.4.1.4. Urgent Care Clinics
                                5.4.1.4.1. Market estimates and forecasts 2021 to 2033 (USD Billion)
                            5.4.1.5. Non-practice Clinics
                                5.4.1.5.1. Market estimates and forecasts 2021 to 2033 (USD Billion)
                        5.4.2. Hospitals
                            5.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Billion)
                        5.4.3. Home
                            5.4.3.1. Market estimates and forecasts 2021 to 2033 (USD Billion)
                        5.4.4. Assisted Living Healthcare Facilitates
                            5.4.4.1. Market estimates and forecasts 2021 to 2033 (USD Billion)
                        5.4.5. Laboratory
                            5.4.5.1. Market estimates and forecasts 2021 to 2033 (USD Billion)
Chapter 6. Point Of Care Diagnostics Market: Regional Estimates & Trend Analysis
                    6.1. Regional Market Share Analysis, 2025 & 2033
                    6.2. Regional Market Dashboard
                    6.3. Global Regional Market Snapshot
                    6.4. Market Size & Forecasts Trend Analysis, 2021 to 2033:
                    6.5. North America
                        6.5.1. U.S.
                            6.5.1.1. Key country dynamics
                            6.5.1.2. Regulatory framework/ reimbursement structure
                            6.5.1.3. Competitive scenario
                            6.5.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Billion)
                        6.5.2. Canada
                            6.5.2.1. Key country dynamics
                            6.5.2.2. Regulatory framework/ reimbursement structure
                            6.5.2.3. Competitive scenario
                            6.5.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Billion)
                        6.5.3. Mexico
                            6.5.3.1. Key country dynamics
                            6.5.3.2. Regulatory framework/ reimbursement structure
                            6.5.3.3. Competitive scenario
                            6.5.3.4. Canada market estimates and forecasts 2021 to 2033 (USD Billion)
                    6.6. Europe
                        6.6.1. Germany
                            6.6.1.1. Key country dynamics
                            6.6.1.2. Regulatory framework/ reimbursement structure
                            6.6.1.3. Competitive scenario
                            6.6.1.4. Germany market estimates and forecasts 2021 to 2033 (USD Billion)
                        6.6.2. UK
                            6.6.2.1. Key country dynamics
                            6.6.2.2. Regulatory framework/ reimbursement structure
                            6.6.2.3. Competitive scenario
                            6.6.2.4. UK market estimates and forecasts 2021 to 2033 (USD Billion)
                        6.6.3. France
                            6.6.3.1. Key country dynamics
                            6.6.3.2. Regulatory framework/ reimbursement structure
                            6.6.3.3. Competitive scenario
                            6.6.3.4. France market estimates and forecasts 2021 to 2033 (USD Billion)
                        6.6.4. Italy
                            6.6.4.1. Key country dynamics
                            6.6.4.2. Regulatory framework/ reimbursement structure
                            6.6.4.3. Competitive scenario
                            6.6.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Billion)
                        6.6.5. Spain
                            6.6.5.1. Key country dynamics
                            6.6.5.2. Regulatory framework/ reimbursement structure
                            6.6.5.3. Competitive scenario
                            6.6.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Billion)
                        6.6.6. Russia
                            6.6.6.1. Key country dynamics
                            6.6.6.2. Regulatory framework/ reimbursement structure
                            6.6.6.3. Competitive scenario
                            6.6.6.4. Russia market estimates and forecasts 2021 to 2033 (USD Billion)
                        6.6.7. Norway
                            6.6.7.1. Key country dynamics
                            6.6.7.2. Regulatory framework/ reimbursement structure
                            6.6.7.3. Competitive scenario
                            6.6.7.4. Norway market estimates and forecasts 2021 to 2033 (USD Billion)
                        6.6.8. Sweden
                            6.6.8.1. Key country dynamics
                            6.6.8.2. Regulatory framework/ reimbursement structure
                            6.6.8.3. Competitive scenario
                            6.6.8.4. Sweden market estimates and forecasts 2021 to 2033 (USD Billion)
                        6.6.9. Denmark
                            6.6.9.1. Key country dynamics
                            6.6.9.2. Regulatory framework/ reimbursement structure
                            6.6.9.3. Competitive scenario
                            6.6.9.4. Denmark market estimates and forecasts 2021 to 2033 (USD Billion)
                    6.7. Asia Pacific
                        6.7.1. Japan
                            6.7.1.1. Key country dynamics
                            6.7.1.2. Regulatory framework/ reimbursement structure
                            6.7.1.3. Competitive scenario
                            6.7.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Billion)
                        6.7.2. China
                            6.7.2.1. Key country dynamics
                            6.7.2.2. Regulatory framework/ reimbursement structure
                            6.7.2.3. Competitive scenario
                            6.7.2.4. China market estimates and forecasts 2021 to 2033 (USD Billion)
                        6.7.3. India
                            6.7.3.1. Key country dynamics
                            6.7.3.2. Regulatory framework/ reimbursement structure
                            6.7.3.3. Competitive scenario
                            6.7.3.4. India market estimates and forecasts 2021 to 2033 (USD Billion)
                        6.7.4. South Korea
                            6.7.4.1. Key country dynamics
                            6.7.4.2. Regulatory framework/ reimbursement structure
                            6.7.4.3. Competitive scenario
                            6.7.4.4. South Korea market estimates and forecasts 2021 to 2033 (USD Billion)
                        6.7.5. Australia
                            6.7.5.1. Key country dynamics
                            6.7.5.2. Regulatory framework/ reimbursement structure
                            6.7.5.3. Competitive scenario
                            6.7.5.4. Australia market estimates and forecasts 2021 to 2033 (USD Billion)
                        6.7.6. Thailand
                            6.7.6.1. Key country dynamics
                            6.7.6.2. Regulatory framework/ reimbursement structure
                            6.7.6.3. Competitive scenario
                            6.7.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Billion)
                    6.8. Latin America
                        6.8.1. Brazil
                            6.8.1.1. Key country dynamics
                            6.8.1.2. Regulatory framework/ reimbursement structure
                            6.8.1.3. Competitive scenario
                            6.8.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Billion)
                        6.8.2. Argentina
                            6.8.2.1. Key country dynamics
                            6.8.2.2. Regulatory framework/ reimbursement structure
                            6.8.2.3. Competitive scenario
                            6.8.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Billion)
                    6.9. MEA
                        6.9.1. South Africa
                            6.9.1.1. Key country dynamics
                            6.9.1.2. Regulatory framework/ reimbursement structure
                            6.9.1.3. Competitive scenario
                            6.9.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Billion)
                        6.9.2. Saudi Arabia
                            6.9.2.1. Key country dynamics
                            6.9.2.2. Regulatory framework/ reimbursement structure
                            6.9.2.3. Competitive scenario
                            6.9.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Billion)
                        6.9.3. UAE
                            6.9.3.1. Key country dynamics
                            6.9.3.2. Regulatory framework/ reimbursement structure
                            6.9.3.3. Competitive scenario
                            6.9.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Billion)
                        6.9.4. Kuwait
                            6.9.4.1. Key country dynamics
                            6.9.4.2. Regulatory framework/ reimbursement structure
                            6.9.4.3. Competitive scenario
                            6.9.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Billion)
Chapter 7. Competitive Landscape
                    7.1. Recent Developments & Impact Analysis by Key Market Participants
                    7.2. Company Categorization
                    7.3. Global Company Market Share Analysis, 2025
                    7.4. Company Heat Map Analysis
                    7.5. Strategy Mapping
                        7.5.1. Expansion
                        7.5.2. Mergers & Acquisition
                        7.5.3. Partnerships & Collaborations
                        7.5.4. New Product Launches
                        7.5.5. Research And Development
                    7.6. Company Profiles
                        7.6.1. F. Hoffmann-La Roche Ltd.
                            7.6.1.1. Company overview
                            7.6.1.2. Financial performance
                            7.6.1.3. Product benchmarking
                            7.6.1.4. Strategic initiatives
                        7.6.2. Qiagen
                            7.6.2.1. Company overview
                            7.6.2.2. Financial performance
                            7.6.2.3. Product benchmarking
                            7.6.2.4. Strategic initiatives
                        7.6.3. Danaher Corporation
                            7.6.3.1. Company overview
                            7.6.3.2. Financial performance
                            7.6.3.3. Product benchmarking
                            7.6.3.4. Strategic initiatives
                        7.6.4. Becton Dickinson (BD)
                            7.6.4.1. Company overview
                            7.6.4.2. Financial performance
                            7.6.4.3. Product benchmarking
                            7.6.4.4. Strategic initiatives
                        7.6.5. bioMérieux
                            7.6.5.1. Company overview
                            7.6.5.2. Financial performance
                            7.6.5.3. Product benchmarking
                            7.6.5.4. Strategic initiatives
                        7.6.6. Abbott
                            7.6.6.1. Company overview
                            7.6.6.2. Financial performance
                            7.6.6.3. Product benchmarking
                            7.6.6.4. Strategic initiatives
                        7.6.7. Siemens Healthcare GmbH
                            7.6.7.1. Company overview
                            7.6.7.2. Financial performance
                            7.6.7.3. Product benchmarking
                            7.6.7.4. Strategic initiatives
                        7.6.8. Werfen
                            7.6.8.1. Company overview
                            7.6.8.2. Financial performance
                            7.6.8.3. Product benchmarking
                            7.6.8.4. Strategic initiatives
                        7.6.9. Nova Biomedical
                            7.6.9.1. Company overview
                            7.6.9.2. Financial performance
                            7.6.9.3. Product benchmarking
                            7.6.9.4. Strategic initiatives
                        7.6.10. Trividia Health, Inc.
                            7.6.10.1. Company overview
                            7.6.10.2. Financial performance
                            7.6.10.3. Product benchmarking
                            7.6.10.4. Strategic initiatives
                        7.6.11. QuidelOrtho Corporation
                            7.6.11.1. Company overview
                            7.6.11.2. Financial performance
                            7.6.11.3. Product benchmarking
                            7.6.11.4. Strategic initiatives
                        7.6.12. Trinity Biotech
                            7.6.12.1. Company overview
                            7.6.12.2. Financial performance
                            7.6.12.3. Product benchmarking
                            7.6.12.4. Strategic initiatives
                        7.6.13. Sekisui Diagnostics
                            7.6.13.1. Company overview
                            7.6.13.2. Financial performance
                            7.6.13.3. Product benchmarking
                            7.6.13.4. Strategic initiatives
                        7.6.14. Orasure Technologies, Inc.
                            7.6.14.1. Company overview
                            7.6.14.2. Financial performance
                            7.6.14.3. Product benchmarking
                            7.6.14.4. Strategic initiatives
                        7.6.15. Spectral Medical, Inc.
                            7.6.15.1. Company overview
                            7.6.15.2. Financial performance
                            7.6.15.3. Product benchmarking
                            7.6.15.4. Strategic initiatives
                        7.6.16. EKF Diagnostics Holdings plc.
                            7.6.16.1. Company overview
                            7.6.16.2. Financial performance
                            7.6.16.3. Product benchmarking
                            7.6.16.4. Strategic initiatives
                        7.6.17. Anbio Biotechnology Co., Ltd.
                            7.6.17.1. Company overview
                            7.6.17.2. Financial performance
                            7.6.17.3. Product benchmarking
                            7.6.17.4. Strategic initiatives
                        7.6.18. AccuBioTech Co., Ltd
                            7.6.18.1. Company overview
                            7.6.18.2. Financial performance
                            7.6.18.3. Product benchmarking
                            7.6.18.4. Strategic initiatives
                        7.6.19. ALPHA LABORATORIES
                            7.6.19.1. Company overview
                            7.6.19.2. Financial performance
                            7.6.19.3. Product benchmarking
                            7.6.19.4. Strategic initiatives

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global point of care diagnostics market, by region, 2021 - 2033 (USD Million)
Table 4 Global point of care diagnostics market, by product, 2021 - 2033 (USD Million)
Table 5 Global point of care diagnostics market, by end use, 2021 - 2033 (USD Million)
Table 6 North America point of care diagnostics market, by region, 2021 - 2033 (USD Million)
Table 7 North America point of care diagnostics market, by product, 2021 - 2033 (USD Million)
Table 8 North America point of care diagnostics market, by end-use, 2021 - 2033 (USD Million)
Table 9 U.S. point of care diagnostics market, by product, 2021 - 2033 (USD Million)
Table 10 U.S. point of care diagnostics market, by end-use, 2021 - 2033 (USD Million)
Table 11 Canada point of care diagnostics market, by product, 2021 - 2033 (USD Million)
Table 12 Canada point of care diagnostics market, by end-use, 2021 - 2033 (USD Million)
Table 13 Mexico point of care diagnostics market, by product, 2021 - 2033 (USD Million)
Table 14 Mexico point of care diagnostics market, by end-use, 2021 - 2033 (USD Million)
Table 15 Europe point of care diagnostics market, by region, 2021 - 2033 (USD Million)
Table 16 Europe point of care diagnostics market, by product, 2021 - 2033 (USD Million)
Table 17 Europe point of care diagnostics market, by end-use, 2021 - 2033 (USD Million)
Table 18 Germany point of care diagnostics market, by product, 2021 - 2033 (USD Million)
Table 19 Germany point of care diagnostics market, by end-use, 2021 - 2033 (USD Million)
Table 20 UK point of care diagnostics market, by product, 2021 - 2033 (USD Million)
Table 21 UK point of care diagnostics market, by end-use, 2021 - 2033 (USD Million)
Table 22 France point of care diagnostics market, by product, 2021 - 2033 (USD Million)
Table 23 France point of care diagnostics market, by end-use, 2021 - 2033 (USD Million)
Table 24 Italy point of care diagnostics market, by product, 2021 - 2033 (USD Million)
Table 25 Italy point of care diagnostics market, by end-use, 2021 - 2033 (USD Million)
Table 26 Spain point of care diagnostics market, by product, 2021 - 2033 (USD Million)
Table 27 Spain point of care diagnostics market, by end-use, 2021 - 2033 (USD Million)
Table 28 Denmark point of care diagnostics market, by product, 2021 - 2033 (USD Million)
Table 29 Denmark point of care diagnostics market, by end-use, 2021 - 2033 (USD Million)
Table 30 Sweden point of care diagnostics market, by product, 2021 - 2033 (USD Million)
Table 31 Sweden point of care diagnostics market, by end-use, 2021 - 2033 (USD Million)
Table 32 Norway point of care diagnostics market, by product, 2021 - 2033 (USD Million)
Table 33 Norway point of care diagnostics market, by end-use, 2021 - 2033 (USD Million)
Table 34 Asia Pacific point of care diagnostics market, by region, 2021 - 2033 (USD Million)
Table 35 Asia Pacific point of care diagnostics market, by product, 2021 - 2033 (USD Million)
Table 36 Asia Pacific point of care diagnostics market, by end-use, 2021 - 2033 (USD Million)
Table 37 China point of care diagnostics market, by product, 2021 - 2033 (USD Million)
Table 38 China point of care diagnostics market, by end-use, 2021 - 2033 (USD Million)
Table 39 Japan point of care diagnostics market, by product, 2021 - 2033 (USD Million)
Table 40 Japan point of care diagnostics market, by end-use, 2021 - 2033 (USD Million)
Table 41 India point of care diagnostics market, by product, 2021 - 2033 (USD Million)
Table 42 India point of care diagnostics market, by end-use, 2021 - 2033 (USD Million)
Table 43 South Korea point of care diagnostics market, by product, 2021 - 2033 (USD Million)
Table 44 South Korea point of care diagnostics market, by end-use, 2021 - 2033 (USD Million)
Table 45 Australia point of care diagnostics market, by product, 2021 - 2033 (USD Million)
Table 46 Australia point of care diagnostics market, by end-use, 2021 - 2033 (USD Million)
Table 47 Thailand point of care diagnostics market, by product, 2021 - 2033 (USD Million)
Table 48 Thailand point of care diagnostics market, by end-use, 2021 - 2033 (USD Million)
Table 49 Latin America point of care diagnostics market, by region, 2021 - 2033 (USD Million)
Table 50 Latin America point of care diagnostics market, by product, 2021 - 2033 (USD Million)
Table 51 Latin America point of care diagnostics market, by end-use, 2021 - 2033 (USD Million)
Table 52 Brazil point of care diagnostics market, by product, 2021 - 2033 (USD Million)
Table 53 Brazil point of care diagnostics market, by end-use, 2021 - 2033 (USD Million)
Table 54 Argentina point of care diagnostics market, by product, 2021 - 2033 (USD Million)
Table 55 Argentina point of care diagnostics market, by end-use, 2021 - 2033 (USD Million)
Table 56 MEA point of care diagnostics market, by region, 2021 - 2033 (USD Million)
Table 57 MEA point of care diagnostics market, by product, 2021 - 2033 (USD Million)
Table 58 MEA point of care diagnostics market, by end-use, 2021 - 2033 (USD Million)
Table 59 South Africa point of care diagnostics market, by product, 2021 - 2033 (USD Million)
Table 60 South Africa point of care diagnostics market, by end-use, 2021 - 2033 (USD Million)
Table 61 Saudi Arabia point of care diagnostics market, by product, 2021 - 2033 (USD Million)
Table 62 Saudi Arabia point of care diagnostics market, by end-use, 2021 - 2033 (USD Million)
Table 63 UAE point of care diagnostics market, by product, 2021 - 2033 (USD Million)
Table 64 UAE point of care diagnostics market, by end-use, 2021 - 2033 (USD Million)
Table 65 Kuwait point of care diagnostics market, by product, 2021 - 2033 (USD Million)
Table 66 Kuwait point of care diagnostics market, by end-use, 2021 - 2033 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Point of care diagnostics market: market outlook
Fig. 14 Point of care diagnostics competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Point of care diagnostics market driver impact
Fig. 20 Point of care diagnostics market restraint impact
Fig. 21 Point of care diagnostics market strategic initiatives analysis
Fig. 22 Point of care diagnostics market: Product movement analysis
Fig. 23 Point of care diagnostics market: Product outlook and key takeaways
Fig. 24 Glucose testing market estimates and forecast, 2021 - 2033
Fig. 25 Hb1Ac testing market estimates and forecast, 2021 - 2033
Fig. 26 Coagulation testing market estimates and forecast, 2021 - 2033
Fig. 27 Fertility/pregnancy market estimates and forecast, 2021 - 2033
Fig. 28 Infectious disease market estimates and forecast, 2021 - 2033
Fig. 29 HIV POC market estimates and forecast, 2021 - 2033
Fig. 30 Pneumonia or streptococcus associated infections market estimates and forecasts, 2021 - 2033
Fig. 31 Respiratory syncytial virus (RSV) POC market estimates and forecasts, 2021 - 2033
Fig. 32 HPV POC market estimates and forecasts, 2021 - 2033
Fig. 33 Influenza/ flu POC market estimates and forecasts, 2021 - 2033
Fig. 34 HCV POC market estimates and forecasts, 2021 - 2033
Fig. 35 MRSA POC market estimates and forecasts, 2021 - 2033
Fig. 36 TB and drug resistant TB POC market estimates and forecasts, 2021 - 2033
Fig. 37 HSV POC market estimates and forecasts, 2021 - 2033
Fig. 38 COVID-19 market estimates and forecasts, 2021 - 2033
Fig. 39 Other infectious diseases estimates and forecasts, 2021 - 2033
Fig. 40 Cardiac markers market estimates and forecasts, 2021 - 2033
Fig. 41 Thyroid stimulating hormone market estimates and forecasts, 2021 - 2033
Fig. 42 Hematology market estimates and forecasts, 2021 - 2033
Fig. 43 Primary care systems estimates and forecasts, 2021 - 2033
Fig. 44 Decentralized clinical chemistry market estimates and forecasts, 2021 - 2033
Fig. 45 Feces market estimates and forecasts, 2021 - 2033
Fig. 46 Lipid testing market estimates and forecasts, 2021 - 2033
Fig. 47 Cancer marker estimates and forecasts, 2021 - 2033
Fig. 48 Blood gas/ electrolytes market estimates and forecasts, 2021 - 2033
Fig. 49 Ambulatory chemistry market estimates and forecasts, 2021 - 2033
Fig. 50 Drug of abuse (DoA) testing market estimates and forecasts, 2021 - 2033
Fig. 51 Autoimmune diseases market estimates and forecasts, 2021 - 2033
Fig. 52 Urinalysis/nephrology market estimates and forecasts, 2021 - 2033
Fig. 53 Point of care diagnostics market: end use movement analysis
Fig. 54 Point of care diagnostics market: end use outlook and key takeaways
Fig. 55 Clinics market estimates and forecasts, 2021 - 2033
Fig. 56 Pharmacy & retail clinics market estimates and forecasts, 2021 - 2033
Fig. 57 Physician office market estimates and forecasts, 2021 - 2033
Fig. 58 Urgent care clinics market estimates and forecasts, 2021 - 2033
Fig. 59 Non-practice clinics market estimates and forecasts, 2021 - 2033
Fig. 60 Hospitals market estimates and forecasts, 2021 - 2033
Fig. 61 Home market estimates and forecasts, 2021 - 2033
Fig. 62 Assisted living healthcare facilities market estimates and forecasts, 2021 - 2033
Fig. 63 Laboratory market estimates and forecasts, 2021 - 2033
Fig. 64 Global point of care diagnostics market: Regional movement analysis
Fig. 65 Global point of care diagnostics market: Regional outlook and key takeaways
Fig. 66 Global point of care diagnostics market share and leading players
Fig. 67 North America market share and leading players
Fig. 68 Europe market share and leading players
Fig. 69 Asia Pacific market share and leading players
Fig. 70 Latin America market share and leading players
Fig. 71 Middle East & Africa market share and leading players
Fig. 72 North America: SWOT
Fig. 73 Europe SWOT
Fig. 74 Asia Pacific SWOT
Fig. 75 Latin America SWOT
Fig. 76 MEA SWOT
Fig. 77 North America, by country
Fig. 78 North America
Fig. 79 North America market estimates and forecasts, 2021 - 2033
Fig. 80 U.S. key country dynamics
Fig. 81 U.S. market estimates and forecasts, 2021 - 2033
Fig. 82 Canada country dynamics
Fig. 83 Canada market estimates and forecasts, 2021 - 2033
Fig. 84 Mexico country dynamics
Fig. 85 Mexico market estimates and forecasts, 2021 - 2033
Fig. 86 Europe
Fig. 87 Europe market estimates and forecasts, 2021 - 2033
Fig. 88 UK country dynamics
Fig. 89 UK market estimates and forecasts, 2021 - 2033
Fig. 90 Germany country dynamics
Fig. 91 Germany market estimates and forecasts, 2021 - 2033
Fig. 92 France country dynamics
Fig. 93 France market estimates and forecasts, 2021 - 2033
Fig. 94 Italy country dynamics
Fig. 95 Italy market estimates and forecasts, 2021 - 2033
Fig. 96 Spain country dynamics
Fig. 97 Spain market estimates and forecasts, 2021 - 2033
Fig. 98 Denmark country dynamics
Fig. 99 Denmark market estimates and forecasts, 2021 - 2033
Fig. 100 Sweden country dynamics
Fig. 101 Sweden market estimates and forecasts, 2021 - 2033
Fig. 102 Norway country dynamics
Fig. 103 Norway market estimates and forecasts, 2021 - 2033
Fig. 104 Asia Pacific
Fig. 105 Asia Pacific market estimates and forecasts, 2021 - 2033
Fig. 106 China country dynamics
Fig. 107 China market estimates and forecasts, 2021 - 2033
Fig. 108 Japan country dynamics
Fig. 109 Japan market estimates and forecasts, 2021 - 2033
Fig. 110 India country dynamics
Fig. 111 India market estimates and forecasts, 2021 - 2033
Fig. 112 Thailand country dynamics
Fig. 113 Thailand market estimates and forecasts, 2021 - 2033
Fig. 114 South Korea country dynamics
Fig. 115 South Korea market estimates and forecasts, 2021 - 2033
Fig. 116 Australia country dynamics
Fig. 117 Australia market estimates and forecasts, 2021 - 2033
Fig. 118 Thailand country dynamics
Fig. 119 Thailand market estimates and forecasts, 2021 - 2033
Fig. 120 Latin America
Fig. 121 Latin America market estimates and forecasts, 2021 - 2033
Fig. 122 Brazil country dynamics
Fig. 123 Brazil market estimates and forecasts, 2021 - 2033
Fig. 124 Argentina country dynamics
Fig. 125 Argentina market estimates and forecasts, 2021 - 2033
Fig. 126 Middle East and Africa
Fig. 127 Middle East and Africa market estimates and forecasts, 2021 - 2033
Fig. 128 South Africa country dynamics
Fig. 129 South Africa market estimates and forecasts, 2021 - 2033
Fig. 130 Saudi Arabia country dynamics
Fig. 131 Saudi Arabia market estimates and forecasts, 2021 - 2033
Fig. 132 UAE country dynamics
Fig. 133 UAE market estimates and forecasts, 2021 - 2033
Fig. 134 Kuwait country dynamics
Fig. 135 Kuwait market estimates and forecasts, 2021 - 2033
Fig. 136 Market share of key market players- Point of care diagnostics market